Crescent Biopharma

CBIO

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-49.9M

EBITDA$-47.23M

EBIT$-47.67M

Pre-tax Income$-160.08M

Net Income$-48.52M

Net Cash$1.53B

Cash Equivalent$25.71M

Total Debt$9.71M

Net Debt$-1.52B

Book Value$12.22M

Net Cash Per Share109.88

Book Value Per Share18.95

Return on Equity (ROE)-712.88%

Return on Assets (ROA)-341.52%

Return on Invested Capital (ROI)-712.88%

Net Profit Margin-368994.20%

Current Ratio1.92

Quick Ratio1.88

Long-Term Debt / Equitynull